HTH-01-091
HTH-01-091 is a potent, selective MELK inhibitor (IC50 10.5 nM) with additional activity against kinases including PIM1-3 and RIPK2. This compound serves as a valuable chemical probe for studying MELK function in breast cancer research, enabling both in vitro and in vivo experimental investigations.
Product Specifications
CAS Number
2000209-42-5
Product Name Alternative
DYRK, CLK2, MLCK, MELK, HTH 01091, HTH 01-091, HTH01091, HTH-01091, HTH-01-091, HTH01-091, Serine kinase, Serinekinase, threonin kinase, threoninkinase, Pim, RIP kinase, RIPkinase, RIPK2
Field of Research
Cell Biology, Epigenetics & Chromatin, Metabolism Research, Signal Transduction, Stem Cell & Developmental Biology
Purity
98.40% (May vary between batches)
Solubility
DMSO:5 mg/mL (10.01 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (2 mM)
Smiles
O=C1N (C2=C3C (=NC=C2CN1) C=CC (=C3) C4=CC (Cl) =C (O) C (Cl) =C4) [C@@H]5CC[C@@H] (CN (C) C) CC5
Molecular Formula
C26H28Cl2N4O2
Molecular Weight
499.43
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2979578 100 µL
TLR2 Recombinant Rabbit mAb, IRDye800CW conjugated
Sign In for Pricing
View Details 
